##FILTER=off-target=Variant marked as 'off-target'.
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 0.1-893-ga055b8e
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group (Neoplasms).
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
#chr	start	end	ref	obs	GS140127_01	GS140550_01	GS140549_01	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	957898	957898	G	T	hom	het	hom	off-target	QUAL=3685;DP=63,55,45;AF=0.98,0.64,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon2/35:c.463+56G>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799064	0.3285	0.3627	2084,.		-2.0720			0.00,0.12	3.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977330	977330	T	C	hom	hom	hom		QUAL=1743;DP=13,26,20;AF=1.00,1.00,1.00;MQM=60	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:exon6/35:c.1178-6T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128292 [benign DISEASE=not specified];			rs2799066	0.8852	0.9233	12149,.	0.7112,0.9515,0.9998,0.9180,0.9530	-0.8450			0.01,0.17	4.36		6.81>6.95		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977570	977570	G	A	hom	hom	hom	off-target	QUAL=1504;DP=17,21,15;AF=1.00,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon7/35:c.1384+28G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263159 [benign DISEASE=not specified];			rs2710876	0.7941	0.8973	10585,.	0.4355,0.9316,0.9726,0.9149,0.9451	-1.5510			0.03,0.18	3.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	978604	978605	CT	-	wt	het	wt	off-target	QUAL=1582;DP=60,194,167;AF=0.00,0.49,0.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon7/35:c.1385-15_1385-14del::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263160 [benign DISEASE=not specified];			rs35881187	0.4792	0.5514	3578,.	0.0943,0.6972,0.7858,0.5385,0.5463	0.0350				4.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981087	981087	A	G	hom	hom	hom	off-target	QUAL=5679;DP=66,65,51;AF=1.00,1.00,1.00;MQM=59	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon14/35:c.2537-26A>G::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263172 [benign DISEASE=not specified];			rs3128098	0.8694	0.9206	11837,.	0.6365,0.9462,0.9999,0.9247,0.9552	-0.5730			0.04,0.15	1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981931	981931	A	G	hom	hom	hom		QUAL=6156;DP=49,96,70;AF=1.00,1.00,1.00;MQM=60	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128297 [benign DISEASE=not specified];			rs2465128		0.8865	10697,.	0.4974,0.9296,0.9677,0.9059,0.8885	-1.7540			0.02,0.07	0.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982941	982941	T	C	hom	hom	hom	off-target	QUAL=9172;DP=47,149,105;AF=1.00,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon20/35:c.3517-12T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263181 [benign DISEASE=not specified];			rs3128102		0.8963	10707,.	0.4469,0.9319,0.9726,0.9133,0.9443	0.1090			0.03,0.17	2.83		6.84>6.29		0.000/0.014		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982994	982994	T	C	hom	hom	hom		QUAL=15338;DP=135,208,143;AF=0.99,1.00,1.00;MQM=59	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain]			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128302 [benign DISEASE=not specified];			rs10267	0.8359	0.9083	11210,.	0.5251,0.9388,0.9995,0.9167,0.9527	0.5010			0.09,0.93	4.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	984302	984302	T	C	het	hom	wt		QUAL=574;DP=9,19,17;AF=0.67,1.00,0.00;MQM=60	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:		regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128307 [benign DISEASE=not specified];			rs9442391	0.5457	0.5883	4023,.	0.2729,0.7050,0.8196,0.5652,0.5594	-1.1240			0.01,0.16	0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985266	985266	C	T	het	hom	wt	off-target	QUAL=583;DP=8,20,11;AF=0.50,1.00,0.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon26/35:c.4745-17C>T::		regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263188 [benign DISEASE=not specified];			rs2275813	0.4952	0.5575	3542,.	0.1480,0.7111,0.8103,0.5353,0.5454	1.9730			0.19,0.18	1.02		11.49>11.28				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985444	985444	G	-	hom	wt	hom	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+41del::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs774490460		0.5598	3743,.	0.7422,0.5306,0.6485,0.4549,0.4871	0.1170				5.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985449	985449	G	A	wt	hom	wt	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+32G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263192 [benign DISEASE=not specified];			rs2799067	0.5256	0.5832	2268,.	0.2618,0.5481,0.5050,0.6172,0.6162	0.1530			0.03,0.07	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985450	985450	G	A	hom	wt	hom	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+33G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs397834473	0.4465	0.5096	3832,.	0.6971,0.4836,0.6056,0.4288,0.4499	-0.4470			0.15,0.26	7.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	987200	987200	C	T	hom	hom	hom		QUAL=10516;DP=63,150,134;AF=0.97,0.99,1.00;MQM=60	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:exon33/35:c.5651+5C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128317 [benign DISEASE=not specified];			rs9803031		0.8871	10698,.	0.4387,0.9320,0.9957,0.9082,0.8828	-0.9360			0.02,0.14	0.29		9.65>8.73		0.000/0.016		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990280	990280	C	T	wt	het	het		QUAL=4766;DP=101,207,174;AF=0.00,0.59,0.51;MQM=60	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain]		regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128319 [benign DISEASE=not specified];			rs4275402		0.6764	5782,.	0.3114,0.7722,0.8138,0.6980,0.6133	-0.7110			0.35,0.88	12.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990380	990380	C	T	hom	het	het		QUAL=12409;DP=162,432,332;AF=0.98,0.49,0.44;MQM=60	AGRN	3'UTR	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::		regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263157 [benign DISEASE=not specified];			rs3121561	0.3434	0.3621	2197,.	0.5233,0.2137,0.1794,0.2920,0.3087	-0.1240			0.05,0.09	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990417	990417	T	C	hom	het	het		QUAL=16506;DP=185,502,389;AF=0.99,0.49,0.46;MQM=60	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2465136	0.3840	0.3941	2699,.		0.3020			0.78,0.96	12.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990517	990517	C	T	hom	hom	het		QUAL=18325;DP=120,372,285;AF=0.99,1.00,0.48;MQM=60	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2710872	0.9179	0.8773	12103,.		-0.4100			0.04,0.14	3.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990773	990773	C	T	hom	hom	het		QUAL=22302;DP=180,404,296;AF=1.00,1.00,0.54;MQM=60	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.183+178C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799072	0.8460	0.8187	10690,.		-0.5960			0.05,0.13	1.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990806	990806	G	A	hom	hom	het		QUAL=24526;DP=222,450,312;AF=0.98,1.00,0.54;MQM=60	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.183+211G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799073		0.8188	10688,.		-0.1840			0.06,0.14	6.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990984	990984	G	A	hom	hom	het		QUAL=15841;DP=146,273,190;AF=1.00,1.00,0.59;MQM=59	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.184-294G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs8014		0.8811	12210,.		-2.5600			0.00,0.06	0.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1956362	1956362	G	A	hom	het	het	off-target	QUAL=6515;DP=81,170,172;AF=1.00,0.48,0.49;MQM=60	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon1/8:c.69-19G>A::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256824 [benign DISEASE=not specified];			rs2376805	0.7756	0.8119	10356,.	0.7935,0.7394,0.7174,0.8311,0.7722	-0.2280			0.00,0.15	0.89		7.68>6.22				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957037	1957037	T	C	het	het	wt		QUAL=6704;DP=159,399,341;AF=0.53,0.49,0.00;MQM=59	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256823 [benign DISEASE=not specified,not provided];			rs2229110	0.5613	0.6469	6668,.	0.7305,0.4736,0.3137,0.6572,0.4740	-1.3800			0.07,0.88	16.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957220	1957220	G	-	het	het	wt	off-target	QUAL=1338;DP=56,79,56;AF=0.52,0.49,0.00;MQM=60	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon4/8:c.470+45del::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];				rs3831907	0.1080	0.1196	281,.	0.2114,0.0549,0.0248,0.1141,0.0777	-4.7340				0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1960674	1960674	C	T	het	wt	het		QUAL=4896;DP=119,386,266;AF=0.50,0.01,0.56;MQM=59	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region]			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256825 [benign DISEASE=not specified];			rs28408173	0.1983	0.1918	416,.	0.0319,0.2378,0.4717,0.1428,0.2543	-0.7780			0.10,0.96	5.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1961408	1961408	C	T	het	wt	het	off-target	QUAL=1606;DP=69,74,64;AF=0.57,0.01,0.50;MQM=59	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon8/8:c.1060-14C>T::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256822 [benign DISEASE=not specified];			rs28431879	0.1999	0.1856	434,.	0.0295,0.2369,0.4852,0.1366,0.2428	-1.4010			0.00,0.11	0.13		7.61>6.94				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2337277	2337277	C	T	het	n/a	n/a		QUAL=107;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60	PEX10	splice_region&intron,intron	PEX10:ENST00000288774:splice_region_variant&intron_variant:LOW:exon5/5:c.973-4G>A::,PEX10:ENST00000447513:splice_region_variant&intron_variant:LOW:exon5/5:c.913-4G>A::,PEX10:ENST00000507596:intron_variant:MODIFIER:exon5/5:c.913-10G>A::		regulatory_region_variant:promoter_flanking_region	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	262791 [benign/likely benign DISEASE=Zellweger syndrome,not specified,not provided];			rs11586985	0.0809	0.1050	168,.	0.0217,0.0584,0.1222,0.1219,0.1099	-1.9740			0.08,0.13	0.61		13.68>13.46,-18.79>-18.77		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2338126	2338126	C	A	wt	het	het	off-target	QUAL=1048;DP=46,55,45;AF=0.00,0.49,0.49;MQM=60	PEX10	intron	PEX10:ENST00000288774:intron_variant:MODIFIER:exon4/5:c.836+33G>T::,PEX10:ENST00000447513:intron_variant:MODIFIER:exon4/5:c.776+33G>T::,PEX10:ENST00000507596:intron_variant:MODIFIER:exon4/5:c.776+33G>T::		regulatory_region_variant:CTCF_binding_site	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];				rs3795269	0.3391	0.4016	2574,.	0.2892,0.4078,0.2649,0.4329,0.3642	0.5730			0.20,0.15	5.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2340200	2340200	T	C	wt	het	het		QUAL=985;DP=43,48,39;AF=0.02,0.54,0.44;MQM=60	PEX10	synonymous	PEX10:ENST00000288774:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]			602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	129884 [benign DISEASE=Zellweger syndrome,not specified,not provided];			rs2494598		0.7735	8639,.	0.5917,0.7710,0.7184,0.8112,0.7245	-6.5230			0.03,0.05	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5922834	5922834	C	A	het	hom	wt	off-target	QUAL=1543;DP=54,42,26;AF=0.37,1.00,0.00;MQM=60	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517:upstream_gene_variant:MODIFIER::::							rs12133533	0.0966	0.1249	305,.	0.0152,0.0833,0.0529,0.1640,0.1101	-0.3700			0.06,0.16	0.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5926507	5926507	T	C	het	hom	wt		QUAL=8832;DP=275,182,155;AF=0.49,0.99,0.00;MQM=60	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:		regulatory_region_variant:open_chromatin_region	607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95683 [benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs555164	0.3197	0.3926	2149,.	0.2002,0.3706,0.2558,0.4222,0.4302	0.2880			0.02,0.92	13.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927031	5927031	A	G	het	hom	wt	off-target	QUAL=3708;DP=80,96,66;AF=0.48,1.00,0.00;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon25/29:c.3558+59T>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs12122135	0.1028	0.1260	296,.		-0.2430			0.02,0.10	0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927943	5927943	G	A	wt	het	wt		QUAL=3628;DP=131,360,269;AF=0.00,0.48,0.00;MQM=60	NPHP4	missense	NPHP4:ENST00000378156:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95682 [likely benign(replaced by megSAP based on classifications:1x1,1x2,3x3) DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0014	0.0037	0,.	0.0012,0.0030,0.0000,0.0060,0.0008	0.0280	T(0.55)	B(0.01)	0.08,0.26	6.43	0.32		gain/donor/5927942-5927943/Medium/6.530789			1	70	0 / 0					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5934490	5934490	A	G	hom	hom	het	off-target	QUAL=5950;DP=74,112,68;AF=0.99,1.00,0.49;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon22/29:c.3231+41T>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260554 [benign DISEASE=not specified];			rs868163	0.5693	0.6453	6624,.	0.7125,0.4989,0.2688,0.6436,0.6148	-3.6260			0.01,0.09	0.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5935162	5935162	A	T	het	het	hom		QUAL=4956;DP=87,128,87;AF=0.38,0.52,1.00;MQM=60	NPHP4	splice_acceptor	NPHP4:ENST00000378156:splice_acceptor_variant:HIGH:exon20/29:c.2818-2T>A::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	167375 [benign DISEASE=not specified];			rs1287637		0.8606	11601,.	0.8938,0.7936,0.8101,0.8244,0.8282	0.4530			0.00,0.85	22.60		0.90>9.27	gain/acceptor/5935162-5935163/High/14.274034			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5937391	5937391	C	T	n/a	hom	wt	off-target	QUAL=157;DP=1,4,87;AF=1.00,1.00,1.00;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon19/29:c.2612-33G>A::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260547 [benign DISEASE=not specified];			rs3747989		0.8299	10876,.	0.9382,0.7305,0.8517,0.8010,0.7363	-2.2310			0.00,0.05	0.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947308	5947308	G	A	wt	het	wt	off-target	QUAL=1780;DP=130,187,146;AF=0.00,0.42,0.01;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon18/29:c.2485+38C>T::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260546 [benign DISEASE=not specified];			rs41280814	0.0863	0.1342	259,.	0.0275,0.0789,0.0795,0.1716,0.1155	-1.8090			0.05,0.17	1.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5965381	5965381	C	T	wt	het	wt		QUAL=2692;DP=208,262,206;AF=0.00,0.43,0.00;MQM=60	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95673 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs12120967	0.0841	0.1317	259,.	0.0271,0.0767,0.0768,0.1672,0.1125	-0.7650			0.03,0.33	1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5987696	5987696	T	C	wt	het	wt	off-target	QUAL=2405;DP=136,184,150;AF=0.00,0.54,0.02;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon11/29:c.1441+13A>G::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95671 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs7520105	0.1412	0.1688	428,.	0.2101,0.0876,0.0770,0.1681,0.1150	0.8260			0.31,0.17	8.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6046432	6046432	C	G	wt	het	wt	off-target	QUAL=789;DP=53,52,46;AF=0.00,0.63,0.02;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon1/29:c.-38-45G>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs1295111	0.3878	0.4104	2658,.		-0.1940			0.09,0.19	1.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6052571	6052571	G	A	wt	het	wt	off-target	QUAL=398;DP=3,39,29;AF=0.00,0.51,0.00;MQM=60	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:exon1/7:c.-53+955G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs61760765	0.0218	0.0351	27,.		-0.2790			0.16,0.33	10.39						1	25	0 / 0					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2(inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6052581	6052581	G	A	n/a	hom	het	off-target	QUAL=1351;DP=2,34,28;AF=1.00,1.00,0.68;MQM=60	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:exon1/7:c.-53+965G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs806109		0.8310	10906,.		0.0500			0.10,0.21	9.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2(inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6526183	6526183	G	A	het	het	wt		QUAL=374;DP=14,20,5;AF=0.43,0.70,0.00;MQM=59	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297904 [benign DISEASE=Distal spinal muscular atrophy];			rs3007417	0.2023	0.1843	1065,.	0.5020,0.0510,0.0004,0.0703,0.0791	-0.6580			0.06,0.14	8.54			gain/donor/6526182-6526183/Medium/3.418541			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526203	6526210	CGTGCTCT	-	het	het	wt		QUAL=369;DP=11,21,6;AF=0.55,0.67,0.00;MQM=59	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.2027	0.1839	1053,.	0.4251,0.0464,0.0006,0.0579,0.0691	0.8620				10.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526241	6526244	CGCC	-	hom	het	wt		QUAL=315;DP=5,15,3;AF=1.00,0.73,0.00;MQM=60	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.2025	0.1838	1069,.		1.0930				6.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526319	6526319	C	T	het	het	wt		QUAL=293;DP=31,33,30;AF=0.35,0.39,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297910 [likely benign DISEASE=Distal spinal muscular atrophy];			rs45604837	0.0863	0.0841	157,.		-0.5600			0.05,0.16	4.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526465	6526465	C	G	het	het	wt		QUAL=3430;DP=81,199,150;AF=0.48,0.54,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297912 [benign DISEASE=Distal spinal muscular atrophy];		MIR3 (SINE/MIR)	rs2986754	0.2043	0.1816	1155,.		-0.5720			0.01,0.10	1.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6527333	6527333	A	G	het	het	wt		QUAL=1564;DP=75,59,53;AF=0.51,0.47,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377737:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297928 [benign DISEASE=Distal spinal muscular atrophy];			rs14708	0.2670	0.2632	1682,.		2.0370			0.00,0.11	11.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529183	6529185	TCC	-	wt	het	wt		QUAL=667;DP=53,109,66;AF=0.38,0.46,0.05;MQM=60	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377737:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377740:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000377748:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000400913:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915:inframe_deletion:MODERATE:exon20/22:c.2334_2336del:p.Glu779del:,PLEKHG5:ENST00000535355:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245:inframe_deletion:MODERATE:exon20/22:c.2403_2405del:p.Glu802del:,PLEKHG5:ENST00000544978:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy,not specified];		(TCC)n (Simple_repeat)	rs113541584	0.0972	0.0848	125,.	0.1890,0.0573,0.0085,0.0753,0.0956	0.1060				12.29					COSM4590012,COSM4590013,COSM911543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529443	6529443	A	G	het	het	wt		QUAL=9602;DP=320,486,391;AF=0.48,0.48,0.00;MQM=60	PLEKHG5	synonymous	PLEKHG5:ENST00000340850:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377737:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377740:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000377748:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000400913:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915:synonymous_variant:LOW:exon19/22:c.2169T>C:p.Ser723=:,PLEKHG5:ENST00000535355:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245:synonymous_variant:LOW:exon19/22:c.2238T>C:p.Ser746=:,PLEKHG5:ENST00000544978:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194881 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs730600	0.2696	0.2647	1701,.	0.5922,0.0937,0.0041,0.1423,0.1761	-0.2200			0.08,0.79	15.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530435	6530435	A	G	het	het	wt	off-target	QUAL=1079;DP=39,55,49;AF=0.46,0.53,0.00;MQM=60	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:exon15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:exon15/20:c.1792-20T>C::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:exon16/21:c.1681-20T>C::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:exon16/21:c.1912-20T>C::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:exon16/21:c.1912-20T>C::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:exon16/21:c.1849-20T>C::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:exon15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:exon16/21:c.1918-20T>C::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:exon16/21:c.1681-20T>C::			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs2986753	0.1717	0.1803	622,.	0.3429,0.0779,0.0039,0.1301,0.1509	-0.4640			0.01,0.12	6.16		7.80>7.76				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530965	6530965	-	G	hom	hom	hom	off-target	QUAL=6161;DP=43,126,96;AF=0.93,0.99,0.95;MQM=59	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:exon13/21:c.1393-22dup::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:exon13/20:c.1504-22dup::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:exon14/21:c.1393-22dup::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:exon14/21:c.1624-22dup::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:exon14/21:c.1624-22dup::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:exon14/21:c.1561-22dup::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:exon13/20:c.1600-22dup::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:exon14/21:c.1630-22dup::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:exon14/21:c.1393-22dup::			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs111312565	1.0000	1.0000	15524,.	1.0000,1.0000,0.9999,1.0000,1.0000					3.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6531589	6531589	C	T	het	het	wt		QUAL=1652;DP=36,114,115;AF=0.67,0.45,0.00;MQM=60	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain]		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297959 [likely benign DISEASE=Distal spinal muscular atrophy];			rs74809741	0.0553	0.0579	62,.	0.0889,0.0369,0.0002,0.0593,0.0518	0.6400	T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.44),T(0.43),T(0.45),T(0.43),T(0.41),T(0.42),T(0.44)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00)	0.73,0.93	15.74	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6533393	6533393	G	C	het	het	wt		QUAL=479;DP=25,25,19;AF=0.44,0.56,0.00;MQM=60	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon9/22:c.881C>G:p.Thr294Ser:,PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon9/22:c.950C>G:p.Thr317Ser:,PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	198895 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs61741379	0.2857	0.2786	1993,.	0.6445,0.0990,0.0072,0.1406,0.1621	0.8480	T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.71),T(0.73),T(0.68),T(0.65),T(0.78),T(0.72),T(0.69)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17	0.62	0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579521	6579521	G	C	het	het	het		QUAL=3392;DP=121,91,77;AF=0.53,0.52,0.45;MQM=60	PLEKHG5	5'UTR,missense	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs17438786	0.0136	0.0242	10,.	0.0050,0.0165,0.0000,0.0326,0.0176	0.0870	 ,T(0.13),T(0.17)	 ,B(0.01),B(0.07)	0.13,0.49	9.74	0.09					10	400	0 / 0					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579607	6579607	C	T	hom	hom	hom		QUAL=20016;DP=179,270,204;AF=1.00,1.00,1.00;MQM=59	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	380860 [benign DISEASE=not specified];			rs1556035	0.7460	0.8595	9987,.	0.5189,0.9267,0.7933,0.8816,0.8645	0.2500			0.07,0.20	6.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579843	6579843	C	T	hom	hom	hom		QUAL=41827;DP=292,585,454;AF=0.99,1.00,1.00;MQM=59	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs1010584	0.7354	0.7734	9752,.		-0.5650			0.03,0.20	5.49						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10318652	10318652	C	G	wt	wt	het		QUAL=2875;DP=314,250,229;AF=0.00,0.00,0.50;MQM=60	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377093:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs12402052	0.2300	0.2766	1045,.	0.0864,0.3446,0.2917,0.2914,0.2293	0.0540			0.81,0.97	11.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10322054	10322054	G	A	wt	wt	het	off-target	QUAL=2022;DP=314,272,179;AF=0.00,0.00,0.46;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon5/46:c.429+26G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon4/47:c.429+26G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon5/20:c.429+26G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon5/48:c.429+26G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon5/20:c.429+26G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs4846209	0.3399	0.3512	1943,.	0.3418,0.3938,0.3671,0.3431,0.2578	0.0780			0.00,0.08	3.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10327407	10327407	A	T	wt	wt	het	off-target	QUAL=1115;DP=257,131,100;AF=0.00,0.00,0.50;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon5/46:c.430-31A>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon4/47:c.430-31A>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon5/20:c.430-31A>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon5/48:c.430-31A>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon5/20:c.430-31A>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs12141246	0.3806	0.3770	2249,.	0.4133,0.3974,0.4087,0.3425,0.2575	-1.8450			0.00,0.07	2.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10328338	10328338	C	T	wt	wt	het	off-target	QUAL=2382;DP=242,187,186;AF=0.00,0.00,0.52;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon7/46:c.720+17C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon6/47:c.720+17C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon7/20:c.720+17C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon7/48:c.720+17C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon7/20:c.720+17C>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	260542 [benign DISEASE=not specified];			rs1339458	0.2540	0.2817	1113,.	0.1535,0.3485,0.2906,0.2919,0.2301	-1.1960			0.06,0.15	5.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10342629	10342629	G	A	wt	het	het	off-target	QUAL=5605;DP=180,224,219;AF=0.01,0.50,0.49;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon13/46:c.1296+38G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon14/47:c.1434+38G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon13/20:c.1296+38G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon15/48:c.1434+38G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon13/20:c.1296+38G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			L3 (LINE/CR1)	rs3748576	0.7127	0.7067	8153,.	0.9335,0.7352,0.5293,0.5971,0.6222	-0.7550			0.01,0.13	2.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10355834	10355834	C	T	wt	wt	het		QUAL=1539;DP=134,158,128;AF=0.01,0.00,0.48;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon17/46:c.1639+10C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon18/47:c.1777+10C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon17/20:c.1639+10C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon19/48:c.1777+10C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon17/20:c.1639+10C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs3753037	0.2640	0.2844	1165,.	0.1871,0.3503,0.2912,0.2920,0.2295	1.0480			0.09,0.20	4.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10357207	10357207	T	-	wt	het	wt	off-target	QUAL=196;DP=183,243,171;AF=0.33,0.30,0.29;MQM=59	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon19/46:c.1905-9del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon20/47:c.2043-9del::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon19/20:c.1905-9del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon21/48:c.2043-9del::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon19/20:c.1905-9del::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			(T)n (Simple_repeat)	rs199617049		0.4250	0,.	0.4308,0.4320,0.4215,0.4277,0.4367	-0.0240				0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366487	10366487	T	G	wt	wt	het		QUAL=2585;DP=248,227,230;AF=0.00,0.00,0.45;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+9183T>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+9183T>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+9183T>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs8019	0.3838	0.3972	2475,.		0.6540			0.00,0.09	2.21			gain/acceptor/10366486-10366487/Medium/2.203688			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366692	10366692	C	G	wt	wt	het		QUAL=2877;DP=288,280,252;AF=0.00,0.00,0.47;MQM=60	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+9388C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+9388C>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+9388C>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::		regulatory_region_variant:enhancer	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			7SLRNA (srpRNA)	rs4623	0.3343	0.3429	1850,.		-0.5090			0.00,0.03	4.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367424	10367424	G	A	wt	wt	het		QUAL=343;DP=114,47,43;AF=0.01,0.00,0.42;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+10120G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+10120G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+10120G>A::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs2004034	0.2316	0.2406	1052,.		-0.1060			0.00,0.11	3.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367591	10367591	T	C	wt	wt	het		QUAL=1134;DP=189,99,87;AF=0.00,0.01,0.59;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+10287T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+10287T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+10287T>C::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs1065828	0.3341	0.3429	1865,.		-0.8920			0.00,0.03	3.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10384176	10384176	-	TTGAAA	het	het	het	off-target	QUAL=5259;DP=226,186,143;AF=0.45,0.42,0.45;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon25/48:c.2537+57_2537+58insTGAAAT::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3831405	0.2326	0.2390	973,.						6.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10394536	10394536	C	G	het	het	het	off-target	QUAL=8177;DP=248,219,152;AF=0.53,0.53,0.48;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon25/46:c.2787-42C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon26/47:c.2925-42C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon27/48:c.2925-42C>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs2276100	0.3339	0.3308	1727,.	0.3230,0.3842,0.3667,0.3197,0.2621	-0.0570			0.09,0.23	6.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10397080	10397080	A	G	wt	het	wt	off-target	QUAL=1131;DP=203,101,79;AF=0.00,0.47,0.00;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon27/46:c.2992-52A>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon28/47:c.3130-52A>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon29/48:c.3130-52A>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs71643087	0.0112	0.0281	17,.		0.0100			0.01,0.20	3.94						6	381	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10420937	10420937	C	T	het	het	het	off-target	QUAL=11846;DP=259,371,298;AF=0.51,0.49,0.51;MQM=59	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon36/46:c.3918-50C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon37/47:c.4056-50C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon38/48:c.4056-50C>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3748579	0.3341	0.3302	1713,.	0.3225,0.3839,0.3664,0.3196,0.2625	-0.4610			0.01,0.18	2.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10425118	10425118	T	-	het	het	het	off-target	QUAL=2916;DP=98,113,92;AF=0.47,0.52,0.45;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon39/46:c.4229-33del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon40/47:c.4367-33del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon41/48:c.4367-33del::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs34161257	0.5240	0.5252	4371,.	0.6622,0.4695,0.3722,0.4743,0.4639	0.5110				4.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10431158	10431158	T	C	het	het	het	off-target	QUAL=7040;DP=219,224,156;AF=0.45,0.53,0.47;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon42/46:c.4687-41T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon43/47:c.4825-41T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon44/48:c.4825-41T>C::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs17411502	0.2490	0.2841	1126,.	0.1495,0.3490,0.2841,0.2958,0.2375	-0.7390			0.03,0.17	11.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10435324	10435324	C	A	het	het	het		QUAL=7167;DP=295,147,115;AF=0.45,0.52,0.57;MQM=60	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000377081:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377086:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain]			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs11121552	0.2316	0.2795	1058,.	0.0874,0.3464,0.2848,0.2956,0.2374	-0.4200			0.27,0.97	8.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436892	10436892	-	AC	het	wt	het		QUAL=4747;DP=131,126,112;AF=0.81,0.52,0.31;MQM=59	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs146112447		0.0594	37,.						2.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436924	10436924	C	T	het	het	wt		QUAL=4747;DP=131,126,112;AF=0.81,0.52,0.31;MQM=59	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-1473C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291594 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs78490707	0.0403	0.0080	11,.		-3.5950			0.04,0.22	1.90						0	5	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438006	10438006	A	T	het	wt	het		QUAL=1323;DP=82,72,54;AF=0.45,0.00,0.48;MQM=59	KIF1B	intron,3'UTR	KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-391A>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::		regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291610 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSg (SINE/Alu)	rs2847347	0.0182	0.0370	20,.		0.2110			0.16,0.23	2.79						1	26	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438687	10438687	C	T	het	het	het		QUAL=12136;DP=254,354,281;AF=0.56,0.51,0.51;MQM=60	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291618 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1536262	0.5465	0.5500	4954,.		-1.2450			0.03,0.16	0.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438892	10438892	G	A	het	het	het		QUAL=8836;DP=282,193,160;AF=0.54,0.52,0.57;MQM=60	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291619 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1002076	0.3337	0.3304	1723,.		0.4730			0.09,0.20	1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10440556	10440556	A	G	het	het	het		QUAL=8812;DP=324,225,182;AF=0.49,0.48,0.49;MQM=51	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291652 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSx (SINE/Alu)	rs1138791	0.3488	0.3605	2039,.		-1.5600			0.00,0.08	9.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10441664	10441664	T	C	het	het	het		QUAL=13580;DP=455,349,272;AF=0.53,0.50,0.44;MQM=60	KIF1B	downstream_gene	KIF1B:ENST00000263934:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581		0.5293	4497,.		0.2790			0.31,0.74	13.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11085004	11085004	-	TGTTT	het	hom	het		QUAL=16984;DP=383,272,258;AF=0.49,0.99,0.50;MQM=60	TARDBP,MASP2,RP4-635E18.8	downstream_gene,upstream_gene	TARDBP:ENST00000240185:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000439080:downstream_gene_variant:MODIFIER::::,RP4-635E18.8:ENST00000607145:upstream_gene_variant:MODIFIER::::				291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs5772439		0.8767	12057,.						10.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP(inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2(inh=AR+AD oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11846092	11846092	-	T	hom	hom	hom		QUAL=4416;DP=114,51,37;AF=0.75,0.90,0.89;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4644dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3639+757dup::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775		0.9797	13625,.						0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846252	11846252	G	A	hom	het	het		QUAL=14846;DP=330,181,158;AF=1.00,0.54,0.50;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4485C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3639+906G>A::		regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292158 [likely benign DISEASE=Neural tube defects, folate-sensitive];		Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.7065	0.6858	7531,.		0.4870			0.00,0.12	5.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846447	11846447	G	A	hom	hom	hom		QUAL=25207;DP=380,216,181;AF=1.00,1.00,1.00;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4290C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-998G>A::		regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292160 [benign DISEASE=Neural tube defects, folate-sensitive];			rs4845884		0.9393	13972,.		-0.7990			0.00,0.10	3.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846660	11846663	TTTT	-	hom	hom	hom		QUAL=1828;DP=78,39,31;AF=0.62,0.56,0.42;MQM=57	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4074_*4077del::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-770_3640-767del::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.7772	0.5146	3151,.		0.3100				1.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847334	11847334	-	GAA	hom	het	het		QUAL=9662;DP=228,222,133;AF=0.97,0.41,0.58;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3400_*3402dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-108_3640-106dup::		regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292171 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs35134728	0.5701	0.5694	5257,.						3.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847759	11847759	C	T	hom	het	het		QUAL=11899;DP=193,292,241;AF=0.98,0.52,0.50;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2978G>A::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon17/20:c.3746-171C>T::		TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292181 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs3737966	0.5585	0.5604	5155,.		0.6900			0.30,0.29	7.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848139	11848139	G	A	wt	het	het		QUAL=2672;DP=121,122,85;AF=0.01,0.48,0.55;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2598C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon18/20:c.3920+35G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292191 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs11559040	0.1268	0.1685	357,.	0.0352,0.0850,0.1026,0.1856,0.2669	-0.6770			0.09,0.19	4.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848879	11848879	A	G	hom	hom	hom		QUAL=18803;DP=241,217,151;AF=1.00,1.00,1.00;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1858T>C::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon20/20:c.4245+76A>G::		regulatory_region_variant:promoter	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292203 [benign DISEASE=Neural tube defects, folate-sensitive];			rs2077360	0.9305	0.9366	13907,.		-0.5590			0.01,0.11	2.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11849447	11849447	A	G	hom	hom	hom		QUAL=17657;DP=146,226,188;AF=1.00,1.00,1.00;MQM=59	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1290T>C::,C1orf167:ENST00000433342:missense_variant:MODERATE:exon21/21:c.4366A>G:p.Arg1456Gly:			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292209 [benign DISEASE=Neural tube defects, folate-sensitive];			rs868014	0.9329	0.9874	13971,.	0.7812,0.9875,1.0000,0.9990,0.9997	-4.9500	 , , , ,T(0.24)	 , , , ,B(0.00)	0.02,0.21	4.70	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11850365	11850365	T	G	hom	het	het		QUAL=18805;DP=311,383,349;AF=1.00,0.48,0.49;MQM=59	MTHFR	3'UTR	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*372A>C::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292223 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs4846049		0.6369	6490,.		-0.6840			0.05,0.19	1.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11851003	11851003	G	C	wt	het	het	off-target	QUAL=3861;DP=207,180,166;AF=0.00,0.43,0.48;MQM=60	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon11/11:c.1876-48C>G::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon12/12:c.1876-48C>G::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon11/11:c.1753-48C>G::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon10/10:c.1753-48C>G::		TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs3818762	0.2475	0.2600	880,.	0.1340,0.1420,0.2153,0.2748,0.4137	-1.1340			0.00,0.02	1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11852300	11852300	C	T	wt	het	het	off-target	QUAL=4633;DP=171,209,197;AF=0.01,0.48,0.47;MQM=60	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon10/11:c.1755+35G>A::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon11/12:c.1755+35G>A::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon10/11:c.1632+35G>A::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon9/10:c.1632+35G>A::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1476413	0.2512	0.2614	890,.	0.1509,0.1389,0.2267,0.2731,0.4203	-1.1060			0.07,0.25	8.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854457	11854457	G	A	hom	hom	hom		QUAL=18479;DP=119,264,204;AF=1.00,1.00,1.00;MQM=60	MTHFR	synonymous	MTHFR:ENST00000376583:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	167306 [benign DISEASE=Neural tube defects, folate-sensitive,not specified];			rs4846051	0.9030	0.9748	13266,.	0.6780,0.9819,0.9991,0.9983,0.9993	0.6310			0.47,0.83	11.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854476	11854476	T	G	wt	het	het		QUAL=7156;DP=166,287,228;AF=0.01,0.54,0.54;MQM=60	MTHFR	missense	MTHFR:ENST00000376583:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:		regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	3521 [likely benign(replaced by megSAP based on classifications:3x1,1x2,1x3) DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stroma tumor,MTHFR deficiency, thermolabile type,Neural tube defects, folate-sensitive,not specified,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2494	0.2890	1116,.	0.1582,0.1594,0.2198,0.3186,0.4116	3.7910	T(0.15),T(0.15),T(0.14),T(0.14)	B(0.07),B(0.07),B(0.01),B(0.01)	0.96,0.96	22.10	0.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854755	11854755	G	A	hom	het	het	off-target	QUAL=3013;DP=70,54,57;AF=1.00,0.39,0.46;MQM=59	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon7/11:c.1289+31C>T::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon8/12:c.1289+31C>T::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon7/11:c.1166+31C>T::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon6/10:c.1166+31C>T::		regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1994798	0.5793	0.6074	5239,.	0.4333,0.7727,0.7596,0.5879,0.4685	-3.8760			0.03,0.15	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	12009955	12009955	C	T	het	het	het		QUAL=6842;DP=122,248,190;AF=0.46,0.49,0.53;MQM=60	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs7529452	0.2678	0.3295	1533,.	0.0589,0.3522,0.3748,0.3160,0.4236	0.9490			0.69,0.83	11.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12009956	12009956	G	A	wt	wt	het		QUAL=2008;DP=146,243,188;AF=0.00,0.00,0.47;MQM=60	PLOD1	missense	PLOD1:ENST00000196061:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:ENST00000376369:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2995	0.2590	1527,.	0.5503,0.0894,0.2527,0.1526,0.2126	1.4500	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03,0.33	14.54	0.15					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12016957	12016957	T	G	wt	wt	het	off-target	QUAL=3761;DP=108,392,311;AF=0.00,0.00,0.50;MQM=60	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon6/18:c.644-17T>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon7/19:c.785-17T>G::			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	384719 [benign DISEASE=not specified];			rs41307745	0.0769	0.0679	50,.	0.0104,0.0250,0.1423,0.0613,0.1356	3.2240			0.64,0.22	8.37		10.55>8.84				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12024235	12024235	C	T	het	het	het		QUAL=1152;DP=18,53,36;AF=0.56,0.53,0.39;MQM=60	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs1130529	0.3484	0.3609	2053,.	0.2929,0.3668,0.3896,0.3275,0.4443	-1.0670			0.12,0.58	7.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12027204	12027204	C	T	het	het	hom	off-target	QUAL=9497;DP=42,211,205;AF=0.45,0.52,1.00;MQM=59	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon16/18:c.1755+56C>T::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon17/19:c.1896+56C>T::		regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs2273293	0.5639	0.5222	4329,.		-3.7710			0.01,0.05	0.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12033113	12033113	A	G	het	het	hom	off-target	QUAL=11228;DP=132,264,209;AF=0.51,0.48,1.00;MQM=60	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon18/18:c.2028+59A>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon19/19:c.2169+59A>G::		regulatory_region_variant:promoter_flanking_region	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs3737961	0.6498	0.5826	5517,.		-0.4870			0.00,0.07	6.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12040203	12040203	A	G	het	het	hom	off-target	QUAL=901;DP=25,24,20;AF=0.44,0.46,1.00;MQM=60	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs2236053		0.5216	4305,.		-0.9190			0.00,0.13	3.36			loss/acceptor/12040203-12040204/Medium/10.214891			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040324	12040324	A	G	het	het	hom		QUAL=4120;DP=30,123,101;AF=0.47,0.36,1.00;MQM=60	MFN2	5'UTR	MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::		regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2236054		0.5264	4410,.		-0.9110			0.00,0.09	9.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040479	12040479	T	C	het	het	hom		QUAL=5101;DP=51,128,113;AF=0.45,0.43,1.00;MQM=60	MFN2	5'UTR	MFN2:ENST00000235329:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::		regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2180183		0.5520	4937,.		-0.2970			0.00,0.05	9.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12062205	12062205	A	G	hom	hom	hom	off-target	QUAL=14516;DP=175,190,138;AF=0.99,0.99,0.99;MQM=59	MFN2	intron	MFN2:ENST00000235329:intron_variant:MODIFIER:exon11/18:c.1160+45A>G::,MFN2:ENST00000444836:intron_variant:MODIFIER:exon10/17:c.1160+45A>G::		regulatory_region_variant:CTCF_binding_site	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];				rs2236057	0.6579	0.6615	6882,.	0.6479,0.5317,0.6765,0.6679,0.7034	-2.0590			0.01,0.11	3.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12071680	12071680	A	G	hom	hom	hom		QUAL=29203;DP=253,418,322;AF=0.99,1.00,0.99;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292381 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs1042842	0.7324	0.7195	8238,.		-0.8580			0.04,0.13	0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072518	12072518	G	C	hom	hom	hom		QUAL=12743;DP=106,172,143;AF=0.99,1.00,1.00;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292393 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs3088064	0.5441	0.5709	5189,.		0.4850			0.22,0.22	2.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072534	12072534	C	T	wt	wt	het		QUAL=1666;DP=102,189,145;AF=0.00,0.00,0.50;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292394 [likely benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs14305	0.0843	0.0541	51,.		0.1270			0.12,0.31	8.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16370428	16370432	GGGGG	-	wt	hom	wt	off-target	QUAL=48;DP=102,4,145;AF=0.00,0.75,0.50;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon1/19:c.-8+61_-8+65del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs140434107	0.9447	0.5123	2076,.		1.3540				4.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16371067	16371067	G	T	het	hom	n/a		QUAL=234;DP=4,5,1;AF=0.75,1.00,1.00;MQM=60	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:		regulatory_region_variant:TF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447107 [benign DISEASE=not specified,not provided];			rs2015352		0.6267	4826,.	0.2881,0.7293,0.6328,0.6333,0.6878	-0.4670	D(0.01)	B(0.16)	0.14,0.92	23.00	0.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372003	16372003	G	C	het	hom	het	off-target	QUAL=6416;DP=54,148,129;AF=0.41,1.00,0.48;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon2/19:c.101-50G>C::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6604910	0.5665	0.6357	4863,.	0.2698,0.7354,0.6801,0.6380,0.7118	0.6820			0.01,0.14	5.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372971	16372971	G	A	hom	hom	hom	off-target	QUAL=12404;DP=81,182,142;AF=1.00,1.00,1.00;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon3/19:c.230-59G>A::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2014841		0.6933	8183,.		-0.2720			0.02,0.13	2.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373124	16373124	A	G	hom	hom	hom		QUAL=23051;DP=179,312,248;AF=0.98,1.00,1.00;MQM=59	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447104 [benign DISEASE=not specified,not provided];			rs5257	0.7404	0.8121	8159,.	0.3791,0.8994,0.9891,0.8093,0.8739	-4.7220			0.03,0.24	0.31			loss/acceptor/16373124-16373125/Medium/12.831041			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373200	16373202	CTT	-	hom	hom	het	off-target	QUAL=9995;DP=121,222,148;AF=0.99,1.00,0.50;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon4/19:c.358+44_358+46del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs35820664	0.7234	0.7861	7533,.	0.3540,0.8883,0.9891,0.7803,0.8442	0.5420				12.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374533	16374533	G	C	hom	hom	hom		QUAL=383;DP=5,3,5;AF=1.00,1.00,1.00;MQM=60	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447105 [benign DISEASE=not specified,not provided];			rs2014562		0.9317	12637,.	0.7589,0.9575,0.9997,0.9439,0.9278	-0.3820			0.06,0.95	6.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374994	16374994	C	T	hom	hom	hom		QUAL=17810;DP=154,245,203;AF=0.99,1.00,1.00;MQM=46	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679:splice_region_variant&intron_variant:LOW:exon6/19:c.577-5C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	381050 [benign/likely benign DISEASE=not specified,not provided];			rs34666902,rs1889788	0.7386	0.8104	8128,.	0.3760,0.8986,0.9890,0.8075,0.8732	-0.3170			0.02,0.22	1.17		4.28>4.16		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375063	16375063	C	G	hom	hom	hom		QUAL=16997;DP=185,216,173;AF=0.99,1.00,1.00;MQM=52	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504916 [benign DISEASE=not specified];			rs45612832,rs1889789		0.9069	11137,.	0.5589,0.9388,0.9997,0.9259,0.9256	-0.0390	T(0.79)	B(0.00)	0.06,0.42	11.39	0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375064	16375064	A	C	hom	hom	hom		QUAL=16997;DP=185,216,173;AF=0.99,1.00,1.00;MQM=52	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504915 [benign DISEASE=not specified];			rs45575235,rs1889790		0.9069	11137,.	0.5589,0.9388,0.9997,0.9258,0.9256	-2.2040			0.07,0.28	9.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375210	16375210	G	A	het	hom	wt	off-target	QUAL=4190;DP=97,100,103;AF=0.48,0.99,0.00;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon7/19:c.655+133G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs9633514	0.3570	0.2951	1647,.		-0.2940			0.09,0.19	7.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375354	16375354	C	T	hom	hom	hom		QUAL=18577;DP=165,236,202;AF=1.00,1.00,1.00;MQM=59	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon7/19:c.656-261C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];			MIR (SINE/MIR)	rs9442227	0.7274	0.6835	7971,.		-0.1220			0.08,0.21	9.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376191	16376191	C	T	hom	hom	hom		QUAL=25479;DP=182,405,313;AF=0.99,1.00,1.00;MQM=44	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447108 [benign DISEASE=not specified,not provided];			rs34188929,rs7367494	0.8299	0.9249	11278,.	0.5573,0.9597,0.9988,0.9484,0.9335	-0.3350	T(1.00),T(1.00)	B(0.00),B(0.01)	0.02,0.12	0.06	0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376230	16376230	-	T	hom	hom	hom	off-target	QUAL=22542;DP=18,441,341;AF=0.67,0.95,0.95;MQM=51	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+33_866+34insT::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59006537		0.9242	10761,.	0.4294,0.9451,0.9983,0.9544,0.9487					1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376232	16376232	A	T	hom	hom	hom	off-target	QUAL=22542;DP=18,441,341;AF=0.67,0.95,0.95;MQM=51	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+35A>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+35A>T::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59924562		0.9253	10777,.	0.4491,0.9459,0.9984,0.9547,0.9477	-2.8490			0.01,0.08	0.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376239	16376239	C	-	hom	hom	hom	off-target	QUAL=24456;DP=79,440,340;AF=1.00,0.99,0.98;MQM=52	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+47del::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+47del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs34589727	0.8301	0.9148	10750,.	0.4231,0.9419,0.9988,0.9470,0.9354	-0.1430				1.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376278	16376278	G	A	hom	hom	hom	off-target	QUAL=30453;DP=138,501,364;AF=0.99,1.00,1.00;MQM=57	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.360-32G>A::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.867-32G>A::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7365182	0.8279	0.9209	11342,.	0.5528,0.9546,0.9999,0.9463,0.9313	1.2090			0.08,0.18	1.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376319	16376319	T	C	hom	hom	hom		QUAL=32761;DP=182,484,361;AF=1.00,1.00,1.00;MQM=59	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	377683 [benign DISEASE=not specified,not provided];			rs7368151	0.8301	0.9168	11434,.	0.5579,0.9485,0.9998,0.9431,0.9271	-4.5300			0.03,0.87	0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376458	16376458	T	C	hom	hom	hom	off-target	QUAL=16879;DP=125,258,183;AF=0.99,1.00,1.00;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon3/12:c.461+47T>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon10/19:c.968+47T>C::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7368166		0.9131	11013,.	0.5505,0.9457,0.9985,0.9398,0.9198	-4.4690			0.00,0.06	6.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378649	16378649	C	G	het	wt	het	off-target	QUAL=483;DP=19,11,19;AF=0.58,0.00,0.68;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon7/12:c.902-44C>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon14/19:c.1409-44C>G::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2297726	0.1625	0.1727	421,.	0.0715,0.1591,0.2995,0.1706,0.1631	0.0970			0.05,0.21	7.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378739	16378739	G	A	wt	wt	het		QUAL=107;DP=27,16,22;AF=0.00,0.00,0.36;MQM=60	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	585703 [benign DISEASE=not provided];			rs34652156	0.0302	0.0371	33,.	0.0580,0.0117,0.0000,0.0274,0.0299	-2.6720			0.05,0.21	0.09						11	435	0 / 0					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380196	16380196	T	C	hom	hom	hom		QUAL=28212;DP=294,369,251;AF=1.00,1.00,1.00;MQM=51	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447094 [benign DISEASE=not specified];			rs5253	0.8383	0.9347	12512,.	0.6863,0.9480,0.8076,0.9843,0.9317	-0.9230	T(0.49),T(0.46)	B(0.00),B(0.00)	0.00,0.10	4.64	0.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380243	16380243	A	G	hom	hom	het		QUAL=15362;DP=131,311,232;AF=1.00,0.99,0.42;MQM=48	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447096 [benign DISEASE=not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.7017	0.7153	8082,.	0.7975,0.5184,0.7947,0.6591,0.5830	0.8530	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19	14.36	0.16					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380252	16380252	C	T	hom	hom	het		QUAL=14358;DP=122,302,218;AF=1.00,1.00,0.43;MQM=48	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447097 [benign DISEASE=not specified,not provided];			rs2275167		0.6412	6486,.	0.5768,0.4929,0.7894,0.6443,0.5281	0.5590			0.14,0.85	15.32			loss/acceptor/16380251-16380252/Medium/4.504692&gain/acceptor/16380252-16380253/Medium/1.970012			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16382877	16382877	A	G	hom	hom	hom	off-target	QUAL=11602;DP=50,203,147;AF=1.00,1.00,0.99;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon11/12:c.1420-40A>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon18/19:c.1930-40A>G::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7517792		0.7963	8798,.	0.7061,0.8840,0.8077,0.7871,0.8423	-2.5310			0.01,0.13	4.55			loss/donor/16382876-16382877/Medium/1.469535			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383329	16383329	-	C	wt	hom	het	off-target	QUAL=125;DP=4,9,26;AF=1.00,0.89,0.27;MQM=46	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon12/12:c.1507-29dup::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon19/19:c.2017-29dup::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs138507185		0.6262	5321,.						2.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383336	16383336	G	C	hom	hom	het	off-target	QUAL=125;DP=4,9,26;AF=1.00,0.89,0.27;MQM=39	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon12/12:c.1507-28G>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon19/19:c.2017-28G>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs12746138		0.7085	6009,.	0.4283,0.8343,0.7670,0.6997,0.7947	-1.1840			0.00,0.06	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383402	16383402	C	T	het	wt	wt		QUAL=694;DP=259,143,140;AF=0.27,0.07,0.00;MQM=34	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6698427		0.0880	0,.	0.0128,0.0033,0.0132,0.0013,0.0025	0.3830			0.26,0.96	13.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383448	16383448	A	C	het	hom	hom		QUAL=15892;DP=223,289,241;AF=0.70,0.89,1.00;MQM=40	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs10803415	0.9010	0.9041	5812,.	0.8429,0.9248,0.6951,0.9399,0.8839	-1.8510			0.00,0.05	7.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383547	16383547	T	C	wt	het	wt		QUAL=531;DP=233,597,398;AF=0.05,0.19,0.00;MQM=31	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057839		0.2174	4,.		0.0660			0.00,0.06	7.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383574	16383574	A	T	het	het	wt		QUAL=887;DP=245,617,380;AF=0.13,0.20,0.00;MQM=32	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057841		0.2479	0,.		0.4380			0.07,0.16	4.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383581	16383581	G	T	het	het	het		QUAL=19836;DP=246,619,382;AF=0.84,0.80,0.52;MQM=37	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057844		0.4996	1874,.		-1.3730			0.03,0.14	1.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383605	16383605	A	G	het	het	het		QUAL=19759;DP=198,648,402;AF=0.74,0.77,0.53;MQM=37	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057845		0.4935	1687,.		-0.5960			0.01,0.17	7.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383668	16383668	T	G	hom	hom	hom		QUAL=32690;DP=170,659,360;AF=0.99,1.00,1.00;MQM=41	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6660218		1.0000	15695,.	1.0000,1.0000,0.9998,0.9999,1.0000	0.1210			0.00,0.08	4.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383682	16383682	G	C	het	het	wt		QUAL=4389;DP=219,649,322;AF=0.19,0.35,0.00;MQM=41	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	402540 [benign DISEASE=not specified];			rs1057854		0.3303	50,.	0.4019,0.2177,0.4238,0.3039,0.2888	-3.2740			0.01,0.12	0.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383742	16383742	C	G	het	het	hom		QUAL=18344;DP=347,516,224;AF=0.55,0.53,1.00;MQM=57	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057857		0.6415	4036,.	0.5897,0.6972,0.4932,0.6536,0.6177	-0.3020			0.04,0.20	7.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383854	16383854	A	G	het	het	wt	off-target	QUAL=616;DP=104,110,56;AF=0.36,0.17,0.00;MQM=38	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region					rs749928769		0.0230	1,.		-0.5780			0.00,0.11	2.89						1	19	0 / 0					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	17312743	17312743	C	T	het	het	hom		QUAL=709;DP=17,25,19;AF=0.41,0.44,0.95;MQM=60	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7136C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:			610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13	0.48	0.24					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313157	17313157	G	A	het	het	hom	off-target	QUAL=9601;DP=83,297,216;AF=0.39,0.50,1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon27/28:c.3236-30C>T::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7550G>A::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon27/28:c.3221-30C>T::		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13	5.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313245	17313256	CCCAGGGCTCCT	-	het	het	wt	off-target	QUAL=2154;DP=59,210,167;AF=0.39,0.50,0.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon26/26:c.3103+44_3103+55del::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon27/28:c.3220+44_3220+55del::		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];				rs143483351	0.3059	0.2349	921,.		1.0320				7.92			gain/acceptor/17313249-17313248/Medium/9.691849			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313343	17313343	G	A	het	het	hom		QUAL=10657;DP=92,282,200;AF=0.48,0.49,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7736G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19	1.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313454	17313454	G	A	het	het	wt		QUAL=2298;DP=59,177,138;AF=0.47,0.44,0.00;MQM=60	ATP13A2,RP1-37C10.3	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:splice_region_variant&intron_variant:LOW:exon26/28:c.3084-3C>T::,ATP13A2:ENST00000341676:splice_region_variant&intron_variant:LOW:exon25/26:c.2952-3C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7847G>A::,ATP13A2:ENST00000452699:splice_region_variant&intron_variant:LOW:exon26/28:c.3069-3C>T::		regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128471 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.3065	0.2819	997,.	0.1706,0.3596,0.5506,0.2392,0.2307	0.9070			0.66,0.95	13.45		9.29>9.90		0.001/0.100		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313654	17313654	C	T	het	het	hom		QUAL=10644;DP=66,280,245;AF=0.52,0.48,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+8047C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:		regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72	13.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314702	17314702	C	T	het	het	wt		QUAL=11015;DP=281,583,493;AF=0.48,0.51,0.01;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+9095C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128468 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2909	0.2494	847,.	0.1518,0.3342,0.5507,0.1933,0.2217	-2.3320			0.06,0.15	6.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314942	17314942	G	A	het	het	hom		QUAL=14038;DP=300,321,262;AF=0.50,0.45,0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+9335G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710 [haloacid dehalogenase-like hydrolase]		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67	14.31			gain/donor/17314941-17314942/Medium/0.871549			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17319011	17319011	G	A	het	het	hom		QUAL=6537;DP=81,152,126;AF=0.48,0.48,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.188-12127G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase]			610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95	14.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17331268	17331268	C	T	wt	wt	het		QUAL=642;DP=135,121,74;AF=0.00,0.00,0.41;MQM=60	ATP13A2,RP1-37C10.3	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],RP1-37C10.3:ENST00000446261:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293803 [uncertain significance DISEASE=Parkinson disease 9];			rs140631323		0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0002	-4.6690			0.02,0.09	4.28					COSM4946978,COSM80893	0	6	0 / 0					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	19198064	19198064	T	G	het	het	wt		QUAL=3438;DP=96,185,149;AF=0.52,0.47,0.00;MQM=59	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2893A>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294333 [likely benign DISEASE=Hyperprolinemia];			rs1138333	0.1793	0.2342	888,.		1.6090			0.00,0.14	8.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198100	19198100	C	G	het	het	wt		QUAL=3379;DP=94,166,144;AF=0.54,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2857G>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294334 [likely benign DISEASE=Hyperprolinemia];			rs1138328	0.1651	0.2278	857,.		0.1130			0.00,0.11	4.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198141	19198141	T	C	het	het	wt		QUAL=3385;DP=120,146,139;AF=0.53,0.48,0.00;MQM=60	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2816A>G::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294336 [likely benign DISEASE=Hyperprolinemia];			rs7366541	0.1799	0.2344	896,.		-1.2020			0.06,0.15	4.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198414	19198414	G	A	het	het	wt		QUAL=4514;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2543C>T::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294341 [likely benign DISEASE=Hyperprolinemia];			rs1140477	0.1935	0.2424	908,.		0.5800			0.12,0.17	4.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198418	19198418	C	T	het	het	wt		QUAL=4514;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2539G>A::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294342 [likely benign DISEASE=Hyperprolinemia];			rs1138269	0.1933	0.2425	908,.		0.1330			0.06,0.16	4.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198576	19198576	A	G	hom	hom	hom		QUAL=29665;DP=367,313,238;AF=1.00,0.99,1.00;MQM=59	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2381T>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294344 [likely benign DISEASE=Hyperprolinemia];			rs1138267		0.6404	6551,.		-5.8090			0.01,0.12	0.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr22	51065524	51065524	C	A	wt	het	wt	off-target	QUAL=261;DP=18,24,21;AF=0.00,0.71,0.00;MQM=60	ARSA	intron	ARSA:ENST00000216124:intron_variant:MODIFIER:exon2/7:c.466-44G>T::,ARSA:ENST00000356098:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000395619:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000395621:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000453344:intron_variant:MODIFIER:exon2/7:c.208-44G>T::,ARSA:ENST00000547307:intron_variant:MODIFIER:exon2/7:c.460-44G>T::,ARSA:ENST00000547805:intron_variant:MODIFIER:exon3/8:c.460-44G>T::		regulatory_region_variant:promoter	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs6151413	0.0086	0.0153	1,.	0.0035,0.0038,0.0075,0.0175,0.0096	-1.5180			0.05,0.14	2.51			loss/acceptor/51065523-51065524/Medium/4.624452			2	259	0 / 0					ARSA(inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chr22	51066537	51066537	G	A	wt	het	wt		QUAL=851;DP=137,76,60;AF=0.00,0.54,0.00;MQM=60	ARSA	5'UTR	ARSA:ENST00000216124:5_prime_UTR_variant:MODIFIER:exon1/8:c.-330C>T::,ARSA:ENST00000356098:5_prime_UTR_variant:MODIFIER:exon1/9:c.-177C>T::,ARSA:ENST00000395619:5_prime_UTR_variant:MODIFIER:exon1/9:c.-132C>T::,ARSA:ENST00000395621:5_prime_UTR_variant:MODIFIER:exon1/9:c.-225C>T::,ARSA:ENST00000453344:5_prime_UTR_variant:MODIFIER:exon1/8:c.-198C>T::,ARSA:ENST00000547307:5_prime_UTR_variant:MODIFIER:exon1/8:c.-336C>T::,ARSA:ENST00000547805:5_prime_UTR_variant:MODIFIER:exon1/9:c.-231C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	342248 [uncertain significance DISEASE=Metachromatic leukodystrophy];			rs558023516	0.0012	0.0068	0,.		-2.1550			0.01,0.07	7.07						0	16	0 / 0					ARSA(inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chrX	154064580	154064580	T	C	hom	hom	hom		QUAL=10757;DP=114,91,124;AF=1.00,1.00,0.99;MQM=60	F8	3'UTR	F8:ENST00000330287:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1292A>G::,F8:ENST00000360256:3_prime_UTR_variant:MODIFIER:exon26/26:c.*1292A>G::			300841 [GENE=F8 PHENOS=Hemophilia A,306700,X-linked recessive];				rs1396947	0.9926	0.9951	6892,7889		-0.8180			0.00,0.04	6.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMIM9(inh=n/a oe_syn=0.62 oe_mis=0.81 oe_lof=0.93), F8(inh=XLR oe_syn=0.90 oe_mis=0.76 oe_lof=0.03)
chrX	154488153	154488153	C	T	hom	wt	het		QUAL=7463;DP=181,78,101;AF=1.00,0.00,0.52;MQM=60	RAB39B	3'UTR	RAB39B:ENST00000369454:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1935G>A::			300774 [GENE=RAB39B PHENOS=Mental retardation,X-linked 72,300271,X-linked recessive/Waisman syndrome,311510,X-linked recessive];	368130 [likely benign DISEASE=Non-syndromic X-linked intellectual disability];			rs782447828	0.0005	0.0012	0,12		-1.1200			0.01,0.13	0.19						1	2	0 / 0					RAB39B(inh=XLR oe_syn=0.85 oe_mis=0.41 oe_lof=0.00)
chrMT	16298	16298	T	C	hom	wt	hom		QUAL=331460;DP=6107,4794,4214;AF=0.99,0.00,0.99;MQM=59	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::							rs148377232															283	58	0 / 0					MT-ND4(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	wt	hom		QUAL=371189;DP=7009,4954,4518;AF=1.00,0.01,1.00;MQM=58	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::							rs3937033															4521	147	0 / 0					MT-ND4(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
